These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 8642257

  • 1. Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and to proliferate.
    Wetzler LM, Ho Y, Reiser H.
    J Exp Med; 1996 Mar 01; 183(3):1151-9. PubMed ID: 8642257
    [Abstract] [Full Text] [Related]

  • 2. Neisseria meningitidis lipopolysaccharide modulates the specific humoral immune response to neisserial porins but has no effect on porin-induced upregulation of costimulatory ligand B7-2.
    Bhasin N, Ho Y, Wetzler LM.
    Infect Immun; 2001 Aug 01; 69(8):5031-6. PubMed ID: 11447183
    [Abstract] [Full Text] [Related]

  • 3. Neisserial porin-induced dendritic cell activation is MyD88 and TLR2 dependent.
    Singleton TE, Massari P, Wetzler LM.
    J Immunol; 2005 Mar 15; 174(6):3545-50. PubMed ID: 15749891
    [Abstract] [Full Text] [Related]

  • 4. The role of B/T costimulatory signals in the immunopotentiating activity of neisserial porin.
    Mackinnon FG, Ho Y, Blake MS, Michon F, Chandraker A, Sayegh MH, Wetzler LM.
    J Infect Dis; 1999 Sep 15; 180(3):755-61. PubMed ID: 10438364
    [Abstract] [Full Text] [Related]

  • 5. The role of porins in neisserial pathogenesis and immunity.
    Massari P, Ram S, Macleod H, Wetzler LM.
    Trends Microbiol; 2003 Feb 15; 11(2):87-93. PubMed ID: 12598131
    [Abstract] [Full Text] [Related]

  • 6. Role of protein tyrosine kinase and Erk1/2 activities in the Toll-like receptor 2-induced cellular activation of murine B cells by neisserial porin.
    MacLeod H, Bhasin N, Wetzler LM.
    Clin Vaccine Immunol; 2008 Apr 15; 15(4):630-7. PubMed ID: 18287580
    [Abstract] [Full Text] [Related]

  • 7. Cutting edge: Immune stimulation by neisserial porins is toll-like receptor 2 and MyD88 dependent.
    Massari P, Henneke P, Ho Y, Latz E, Golenbock DT, Wetzler LM.
    J Immunol; 2002 Feb 15; 168(4):1533-7. PubMed ID: 11823477
    [Abstract] [Full Text] [Related]

  • 8. Neisserial porins may provide critical second signals to polysaccharide-activated murine B cells for induction of immunoglobulin secretion.
    Snapper CM, Rosas FR, Kehry MR, Mond JJ, Wetzler LM.
    Infect Immun; 1997 Aug 15; 65(8):3203-8. PubMed ID: 9234776
    [Abstract] [Full Text] [Related]

  • 9. Porins and lipopolysaccharide from Salmonella typhimurium regulate the expression of CD80 and CD86 molecules on B cells and macrophages but not CD28 and CD152 on T cells.
    Galdiero M, Pisciotta MG, Galdiero E, Carratelli CR.
    Clin Microbiol Infect; 2003 Nov 15; 9(11):1104-11. PubMed ID: 14616726
    [Abstract] [Full Text] [Related]

  • 10. Innate immune function of the neisserial porins and the relationship to vaccine adjuvant activity.
    Wetzler LM.
    Future Microbiol; 2010 May 15; 5(5):749-58. PubMed ID: 20441547
    [Abstract] [Full Text] [Related]

  • 11. Carrier-mediated enhancement of cognate T cell help: the basis for enhanced immunogenicity of meningococcal outer membrane protein polysaccharide conjugate vaccine.
    Pérez-Melgosa M, Ochs HD, Linsley PS, Laman JD, van Meurs M, Flavell RA, Ernst RK, Miller SI, Wilson CB.
    Eur J Immunol; 2001 Aug 15; 31(8):2373-81. PubMed ID: 11500820
    [Abstract] [Full Text] [Related]

  • 12. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
    Trentin L, Perin A, Siviero M, Piazza F, Facco M, Gurrieri C, Galvan S, Adami F, Agostini C, Pizzolo G, Zambello R, Semenzato G.
    Cancer; 2000 Sep 15; 89(6):1259-68. PubMed ID: 11002221
    [Abstract] [Full Text] [Related]

  • 13. Immunopotentiating ability of neisserial major outer membrane proteins. Use as an adjuvant for poorly immunogenic substances and potential use in vaccines.
    Wetzler LM.
    Ann N Y Acad Sci; 1994 Aug 15; 730():367-70. PubMed ID: 8080211
    [No Abstract] [Full Text] [Related]

  • 14. B cell responses to a peptide epitope. IX. The kinetics of antigen binding differentially regulates costimulatory capacity of activated B cells.
    Vijayakrishnan L, Natarajan K, Manivel V, Raisuddin S, Rao KV.
    J Immunol; 2000 Jun 01; 164(11):5605-14. PubMed ID: 10820235
    [Abstract] [Full Text] [Related]

  • 15. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function.
    Hathcock KS, Laszlo G, Pucillo C, Linsley P, Hodes RJ.
    J Exp Med; 1994 Aug 01; 180(2):631-40. PubMed ID: 7519245
    [Abstract] [Full Text] [Related]

  • 16. The ability of B cells and dendritic cells to present antigen increases during ontogeny.
    Muthukkumar S, Goldstein J, Stein KE.
    J Immunol; 2000 Nov 01; 165(9):4803-13. PubMed ID: 11046003
    [Abstract] [Full Text] [Related]

  • 17. IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells.
    Nikcevich KM, Gordon KB, Tan L, Hurst SD, Kroepfl JF, Gardinier M, Barrett TA, Miller SD.
    J Immunol; 1997 Jan 15; 158(2):614-21. PubMed ID: 8992975
    [Abstract] [Full Text] [Related]

  • 18. Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus.
    Nagafuchi H, Shimoyama Y, Kashiwakura J, Takeno M, Sakane T, Suzuki N.
    Clin Exp Rheumatol; 2003 Jan 15; 21(1):71-7. PubMed ID: 12673892
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of neisserial serum resistance.
    Vogel U, Frosch M.
    Mol Microbiol; 1999 Jun 15; 32(6):1133-9. PubMed ID: 10383755
    [Abstract] [Full Text] [Related]

  • 20. IL-4 treatment of small splenic B cells induces costimulatory molecules B7-1 and B7-2.
    Stack RM, Lenschow DJ, Gray GS, Bluestone JA, Fitch FW.
    J Immunol; 1994 Jun 15; 152(12):5723-33. PubMed ID: 7515912
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.